Agenus to Participate in September Investor Conferences
- None.
- None.
-
2023 Wells Fargo Healthcare Conference – Fireside chat presentation will be held in-person on Thursday, September 7th, 2023, at 11:00 a.m. ET in
Boston, MA. A live webcast and replay will be accessible on the company’s website at https://investor.agenusbio.com/events-and-presentations.
-
Baird 2023 Global Healthcare Conference– Fireside chat presentation will be held in person on Tuesday, September 12th, 2023, at 4:20 p.m. ET, in
New York, NY . This content is for Baird clients attending the conference. There will not be a webcast replay.
-
HC Wainwright 25th Annual Global Investment Conference – Fireside chat presentation will be held in-person on Wednesday, September 13th, 2023, at 11:00 a.m. ET, in
New York, NY . A live webcast and replay will be accessible on the company’s website at https://investor.agenusbio.com/events-and-presentations.
About Agenus
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20230828602083/en/
Investor Contact
917-362-1370
investor@agenusbio.com
Media Contact
781-674-4784
communications@agenusbio.com
Source: Agenus Inc.
